1. CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy
   Xiaofei Li et al, 2022, OncoImmunology CrossRef
2. Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden
   Sofia Sagredou et al, 2021, Pharmaceutics CrossRef
3. Tumor microenvironment-aware, single-transcriptome prediction of microsatellite instability in colorectal cancer using meta-analysis
   Mi-Kyoung Seo et al, 2022, Scientific Reports CrossRef
4. Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
   Marine Fidelle et al, 2020, Frontiers in Immunology CrossRef
5. MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It
   Elena Shklovskaya et al, 2021, International Journal of Molecular Sciences CrossRef
6. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer
   Aung Kyi Thar Min et al, 2021, Cancer Immunology, Immunotherapy CrossRef
7. Blood glutamate scavengers increase pro-apoptotic signaling and reduce metastatic melanoma growth in-vivo
   Yona Goldshmit et al, 2021, Scientific Reports CrossRef
8. Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression
   Bin-Jin Hwang et al, 2022, Journal for ImmunoTherapy of Cancer CrossRef
9. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy
   Pasquale Sibilio et al, 2022, Biology Direct CrossRef
10. Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer
    Akinao Kaneta et al, 2022, Cancer Immunology, Immunotherapy CrossRef
11. Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer
    Yuko Nakayama et al, 2020, Gastric Cancer CrossRef
12. Single‐cell dissection reveals the role of DNA damage response patterns in tumor microenvironment components contributing to colorectal cancer progression and immunotherapy
    Xin Shen et al, 2023, Genes to Cells CrossRef
13. PPARγ induces PD-L1 expression in MSS+ colorectal cancer cells
    Tobias Gutting et al, 2021, OncoImmunology CrossRef
14. Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis
    Yu Liang et al, 2022, Disease Markers CrossRef
15. The Mechanisms Leading to Distinct Responses to PD-1/PD-L1 Blockades in Colorectal Cancers With Different MSI Statuses
    Guanglin Cui, 2021, Frontiers in Oncology CrossRef
16. Analysis of multi-omics differences in left-side and right-side colon cancer
    Yanyi Huang et al, 2021, PeerJ CrossRef
17. PROGNOSTIC ROLE OF MOLECULAR SUBTYPES OF COLON CANCER. A CURRENT VIEW ON THE PROBLEM
    L. E. Sinyansky et al, 2021, Siberian journal of oncology CrossRef
18. Interleukin-12: Structure, Function, and Its Impact in Colorectal Cancer
    Ziwei Zhu et al, 2024, Journal of Interferon & Cytokine Research CrossRef
19. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target
    Haizhou Wang et al, 2022, Journal for ImmunoTherapy of Cancer CrossRef